You are on Trendlyne United States. Click here to go to India website or make United States as your default

0.26 -0.01 (-3.70%)

90.08% Fall from 52W High

69,964 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Eterna Therapeutics Inc

The latest disclosure was made by Peter Cicala in Eterna Therapeutics Inc where a trade of 51,485 Stock Option (Right to buy) done was reported to US exchanges on Feb. 7, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Peter Cicala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 51,485 51,485 - - Stock Option (Right to buy)
Sanjeev Luther Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 1,123,350 1,123,350 - - Stock Option (right to buy)
William A. Wexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 124,533 124,533 - - Stock Option (right to buy)
Sandra M. Gurrola Sr. VP of Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 150,000 150,000 - - Stock Option (Right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 72,074 72,074 - - Stock Option (Right to buy)
Elena Ratner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2025 140,078 140,078 - - Stock Option (Right to buy)
Charles Cherington Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Sep 2024 2,475,524 0 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Sep 2024 3,125,976 0 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 83,916 2,475,524 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Sep 2024 523,512 0 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 261,756 818,221 - - Common Stock
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 4,768,783 5,587,004 - - Common Stock
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 5,420,823 12,245,589 - - Common Stock
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 1,237,762 6,824,766 - - Common Stock
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 1,562,988 13,808,577 - - Common Stock
Charles Cherington Ten Percent Owner 23 Sep 2024 2,819,546 16,628,123 - 0.5 1,409,773 Common Stock
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2024 83,916 2,391,608 - - Warrants (right to buy)
Sandra M. Gurrola Sr. VP of Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.94 per share. 21 Jun 2024 180 1,185 - 1.9 349 Common Stock
Sandra M. Gurrola Sr. VP of Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jun 2024 437 437 - - Restricted Stock Units
Sandra M. Gurrola Sr. VP of Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jun 2024 437 1,365 - - Common Stock
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 124,525 124,525 - - Stock Option (Right to buy)
Sandra M. Gurrola Sr. VP of Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 80,000 80,000 - - Stock Option (Right to buy)
Peter Cicala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 88,946 88,946 - - Stock Option (Right to buy)
Sanjeev Luther Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 1,685,218 1,685,218 - - Stock Option (right to buy)
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Dec 2023 2,307,692 2,307,692 - - Warrants (right to buy)
Cherington Charles Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Dec 2023 3,125,976 3,125,976 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Dec 2023 523,512 523,512 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner 14 Dec 2023 523,512 0 - - Warrants (right to buy)
Charles Cherington Ten Percent Owner 14 Dec 2023 2,307,692 0 - - Warrants (right to buy)
Brant C. Binder Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jul 2023 83,916 83,916 - - Warrants (right to buy)
Matthew Angel Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2023 132,003 132,003 - - Stock Option (right to buy)
Nicholas J. Singer Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 02 Dec 2022 424,928 424,928 - - Warrants (right to buy)
Nicholas J. Singer Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 02 Dec 2022 141,644 141,644 - - Warrants (right to buy)
Nicholas J. Singer Director Purchase of securities on an exchange or from another person at price $ 3.28 per share. 02 Dec 2022 212,464 266,214 - 3.3 696,882 Common Stock
Nicholas J. Singer Director Purchase of securities on an exchange or from another person at price $ 3.28 per share. 02 Dec 2022 70,822 121,822 - 3.3 232,296 Common Stock
Charles Cherington Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.28 per share. 02 Dec 2022 261,756 556,465 - 3.3 858,560 Common Stock
Charles Cherington Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 02 Dec 2022 523,512 523,512 - - Warrants (right to buy)
Roger Sidhu Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2022 20,163 20,163 - - Common Stock
Roger Sidhu Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2022 20,163 60,487 - - Restricted Stock Units
William A. Wexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 152,100 152,100 - - Stock Option (right to buy)
Nicholas J. Singer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 146,100 146,100 - - Stock Option (right to buy)
Nicholas J. Singer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 165,800 165,800 - - Stock Option (right to buy)
Charles Cherington Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 165,800 165,800 - - Stock Option (right to buy)
Gregory Fiore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 95,100 95,100 - - Stock Option (right to buy)
Gregory Fiore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 165,800 165,800 - - Stock Option (right to buy)
Matthew Angel Director, Interim President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 2,487,003 2,487,003 - - Stock Option (right to buy)
William A. Wexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 165,800 165,800 - - Stock Option (right to buy)
Charles Cherington Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 215,100 215,100 - - Stock Option (right to buy)
Kevin D'Amour Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2022 17,573 17,573 - - Common Stock
Kevin D'Amour Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.55 per share. 28 Jun 2022 6,077 11,496 - 0.6 3,363 Common Stock
Kevin D'Amour Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2022 17,573 52,717 - - Restricted Stock Units
Sandra M. Gurrola Vice President of Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. 21 Jun 2022 3,586 13,367 - 0.5 1,709 Common Stock
Sandra M. Gurrola Vice President of Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jun 2022 8,750 26,250 - - Restricted Stock Units
Sandra M. Gurrola Vice President of Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jun 2022 8,750 16,953 - - Common Stock
Andrew C. Jackson Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2022 664,800 664,800 - - Stock Option (right to buy)
Roger Sidhu Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2022 142,100 142,100 - - Stock Option (Right to buy)
Jay Sial Chief Administration Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2022 117,200 117,200 - - Stock Option (Right to buy)
Kevin D'Amour Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2022 138,400 138,400 - - Stock Option (Right to buy)
Howard J. Federoff Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2022 413,700 413,700 - - Stock Option (Right to buy)
Sandra M. Gurrola Vice President of Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2022 114,500 114,500 - - Stock Option (Right to buy)
Erin S. Enright Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 67,000 67,000 - - Stock Option (right to buy)
Heather B. Redman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2022 67,000 67,000 - - Stock Option (right to buy)
Roger Sidhu See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Sep 2021 80,650 80,650 - - Restricted Stock Unit
Roger Sidhu See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Sep 2021 161,300 161,300 - - Stock Option
Jay Sial See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2021 71,000 71,000 - - Stock Option
Jay Sial See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2021 35,700 35,700 - - Restricted Stock Unit
George P. Denny Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 12.00 per share. 06 Jul 2021 1 3 - 12 12 Common Stock
George P. Denny Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 14.00 per share. 06 Jul 2021 1 2 - 14 14 Common Stock
George P. Denny Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 14.00 per share. 06 Jul 2021 1 1 - 14 14 Common Stock
George P. Denny Ten Percent Owner Sale of securities on an exchange or to another person at price $ 16.06 per share. 06 Jul 2021 75,000 4,775,117 - 16.1 1,204,688 Common Stock
Kevin D'Amour See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2021 140,580 140,580 - - Stock Option
Kevin D'Amour See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2021 70,290 70,290 - - Restricted Stock Unit
Sandra M. Gurrola Vice President of Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2021 35,000 35,000 - - Restricted Stock Unit
Charles Cherington Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 15.74 per share. 16 Jun 2021 198,000 5,896,101 - 15.7 3,117,213 Common Stock
Charles Cherington Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 16.30 per share. 16 Jun 2021 2,000 5,894,101 - 16.3 32,595 Common Stock
Charles Cherington Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 15.73 per share. 16 Jun 2021 200,000 6,094,101 - 15.7 3,146,760 Common Stock
Howard J. Federoff Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2021 2,627,915 2,627,915 - - Stock Option
Howard J. Federoff Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2021 597,253 597,253 - - Stock Option
Allen Wolff Director, Former Director and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. 24 Mar 2021 9,944 128,520 - 2.7 26,550 Common Stock
Sandra M. Gurrola Former SVP of Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. 24 Mar 2021 6,094 21,617 - 2.7 16,271 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures